Phillips Medisize is proud to exhibit at the CPHI 2025 conference October 28–30 in Frankfurt, Germany.
Visit us at BOOTH 5.0D100 in the Contract Manufacturing zone to explore our latest advancements in parenteral and inhalation drug delivery devices, as well as our global and regional contract manufacturing and R&D capabilities.
Interested in meeting with one of our subject-matter experts at CPHI? Please fill out the Contact Us form, and we will follow up with you.
Drug Delivery Solutions
From discovery to delivery, world’s leading pharmaceutical companies select Phillips Medisize to help them engineer and manufacture their life-enhancing and lifesaving drug delivery devices. We leverage our 60 years of CDMO experience to design, develop and produce patient-centric devices, including parenteral, inhalation and ocular drug delivery devices. With the 2025 Vectura acquisition, our offering has expanded to include inhaled drug development.